The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for S Narayanan


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a novel small molecule agonist scaffold for the APJ receptor.EBI
Rti International
Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.EBI
Orchid Chemicals & Pharmaceuticals
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.EBI
Bristol-Myers Squibb R & D
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series.EBI
Arena Pharmaceuticals
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.EBI
Astrazeneca
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists.EBI
Arena Pharmaceuticals
Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.EBI
Research Triangle Institute
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists.EBI
Arena Pharmaceuticals
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.EBI
Astrazeneca
Lead optimization of 1,4-azaindoles as antimycobacterial agents.EBI
Astrazeneca
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.EBI
Astrazeneca
Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.EBI
The University of Mississippi
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase.EBI
University of Kansas
Synthesis and evaluation of some novel dibenzo[b,d]furan carboxylic acids as potential anti-diabetic agents.EBI
Glenmark Research Center
Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents.EBI
Glenmark Research Center
Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.EBI
Orchid Chemicals and Pharmaceuticals Ltd.
Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor.EBI
Rti International
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice.EBI
Rti International
In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors.EBI
Orchid Pharma
Identification of potent pyrazole based APELIN receptor (APJ) agonists.EBI
Rti International
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.EBI
Astrazeneca
Glycosidase inhibitors and uses thereofBDB
Alectos Therapeutics